We talked to Dr. Marcella Nunez-Smith, a Yale internist and an expert on the structural barriers to equitable treatment and health outcomes for people of color and other vulnerable populations.

Yale SOM’s Jason Abaluck and his co-authors calculated that the Medicare Advantage plans appreciably influence the survival rates of their enrollees. Shutting down the plans with the highest mortality rates could save thousands of lives per year.  

Nicolas Encina ’10 and his colleagues at Ariadne Labs have been demonstrating the potential of a collaborative, multidisciplinary process for designing and scaling simple improvements to healthcare—and also its limits.

According to a new study co-authored by Yale SOM’s Marissa King, most patients aren’t staying on the drug long enough to get its benefit, and it isn’t reaching young people.

Using a computer model, the researchers found that weekly testing will keep outbreaks under control under relatively optimistic scenarios, but that testing every three days would be more reliable.